CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
ERAMET seeks to improve the drug development process for pediatric and orphan drugs by creating a transparent ecosystem that utilizes modeling and simulation methods. The project aims to establish credible evidence sources for regulatory procedures and enhance decision-making in drug development.
ERAMET will provide an integrated approach for developers and regulators’ decision-making for paediatric and orphan drugs, centred on the drug development questions.
This will constitute a transparent ecosystem for drug development and assessment, that will facilitate the adoption of modelling and simulation (M&S) methods and related data types (including real word data such as registries and electronic healthcare data).The overall objective of ERAMET is to provide and implement a framework for…
UNIVERSITE DE NAMUR
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Norway
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Belgium, Sint-Joost-Ten-Node
Type: Research institute
Activity type: Research Organisations
SME: No
Spain, Valencia
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
CONSORZIO PER VALUTAZIONI BIOLOGICHE E FARMACOLOGICHE
Italy, Bari
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
